Workflow
GCH TECHNOLOGY CO.(688625)
icon
Search documents
呈和科技(688625) - 关于参加广东辖区2024年投资者网上集体接待日活动的公告
2024-09-09 10:34
证券代码:688625 证券简称:呈和科技 公告编号: 2024-033 呈和科技股份有限公司 关于参加广东辖区 2024 年投资者 网上集体接待日活动的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 为进一步加强与投资者的互动交流,呈和科技股份有限公司(以下简称"公司")将参 加由广东证监局、广东上市公司协会联合举办的"坚定信心 携手共进 助力上市公司提升投 资价值——2024 广东辖区上市公司投资者关系管理月活动投资者集体接待日",现将相关事 项公告如下: | --- | |----------------------------------------------------------------------------------------| | | | 本次活动将采用网络远程的方式举行, 投资者可登录 | | ( http://rs.p5w.net )参与本次互动交流,活动时间为 2024 年 9 | | 16:30 。届时公司高管将在线就 2024 年半年度业绩、公司治理、发展战略、经营状况、融资 ...
呈和科技:中信证券股份有限公司关于呈和科技股份有限公司2024半年度持续督导跟踪报告
2024-09-04 11:14
中信证券股份有限公司 关于呈和科技股份有限公司 2024 半年度持续督导跟踪报告 中信证券股份有限公司(以下简称"中信证券"或"保荐人")作为呈和科 技股份有限公司(以下简称"呈和科技"或"公司"或"上市公司")2023 年 度以简易程序向特定对象发行股票项目的保荐人,于 2023 年 3 月 2 日与公司签 订保荐协议,自签署保荐协议之日起,承接原保荐人中信建投证券股份有限公司 尚未完成的持续督导工作。根据《证券发行上市保荐业务管理办法》《上海证券 交易所科创板股票上市规则》等相关规定,中信证券履行持续督导职责,并出具 本持续督导半年度跟踪报告。 一、持续督导工作概述 1、保荐人制定了持续督导工作制度,制定了相应的工作计划,明确了现场 检查的工作要求。 2、保荐人已与公司签订保荐协议,该协议已明确了双方在持续督导期间的 权利义务,并报上海证券交易所备案。 3、本持续督导期间,保荐人通过与公司的日常沟通、现场回访等方式开展 持续督导工作,并于 2024 年 8 月 1 日现场查看了公司及募投项目情况。 4、本持续督导期间,保荐人根据相关法规和规范性文件的要求履行持续督 导职责,具体内容包括: (1)查阅公司章 ...
呈和科技:成核剂、水滑石等主业持续增长,支撑公司业绩稳健提升
Tai Ping Yang· 2024-09-03 00:03
Investment Rating - The report maintains a "Buy" rating for the company, Chenghe Technology (688625) [1][2] Core Views - The company's main businesses, including nucleating agents and hydrotalcite, continue to grow, supporting a steady increase in performance [1][2] - In the first half of 2024, the company achieved operating revenue of 414 million yuan, a year-on-year increase of 12.0%, and a net profit attributable to shareholders of 128 million yuan, up 17.4% year-on-year [2][3] - The company is focusing on product iteration and upgrading, which has improved overall sales gross margin to 45.09%, an increase of 1.56 percentage points compared to 2023 [2][3] Financial Performance - In Q2 2024, the company reported operating revenue of 223 million yuan, a year-on-year increase of 11.7%, and a net profit of 65.98 million yuan, up 14.7% year-on-year [2] - The nucleating agent segment generated revenue of 253 million yuan, a year-on-year increase of 27.67%, while the synthetic hydrotalcite business achieved revenue of 5.8 million yuan, up 20.54% year-on-year [2] - The company has maintained high R&D investment, resulting in the authorization of 7 new invention patents in 2023, with ongoing projects expected to support long-term growth [2][3] Earnings Forecast and Financial Indicators - The forecasted earnings per share (EPS) for 2024, 2025, and 2026 are 1.97 yuan, 2.32 yuan, and 2.72 yuan, respectively [3] - The projected operating revenue for 2024 is 970 million yuan, with a growth rate of 21.28% [3] - The net profit for 2024 is expected to be 266 million yuan, reflecting a growth rate of 17.62% [3]
呈和科技(688625) - 投资者关系活动记录表
2024-08-26 07:37
证券代码:688625 证券简称:呈和科技 呈和科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |----------|---------------------------|-------------------| | | □特定对象调研 □分析师会议 | | | 投资者关 | □媒体采访 | 业绩说明会 | | 系活动 | □新闻发布会 □路演活动 | | | 类 别 | □现场参观 | 其他 (电话会议) | 参与单位 详见附表 名称及人 员姓名 时间 2024年8月22日15:30-16:30 地点 公司会议室 副总经理兼董事会秘书 杨燕芳 上 市 公司 财务总监 余志亮 接 待人 员 证券事务代表 陈淑娴 姓 名 一、公司经营情况介绍 公司是一家生产制造环保、安全、高性能的特种高分子材料助剂的高新技 术企业,经认定为国家级"专精特新"小巨人企业、国家级制造业单项冠军企 业、国家级"绿色工厂"、国家级博士后科研工作站。主营产品处于高性能树 脂及改性塑料制造行业的上游核心环节,是国家重点发展的高性能树脂材料实 投资者关 现国产化的关键材料。可显著改善通用树脂产品的光学、力 ...
呈和科技:关于持股5%以上股东与其股东之间协议转让公司股份完成过户登记的公告
2024-08-22 10:44
证券代码:688625 证券简称:呈和科技 公告编号:2024-032 呈和科技股份有限公司 关于持股 5%以上股东与其股东之间协议转让公司股份 完成过户登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、股份协议转让情况 呈和科技股份有限公司(以下简称"公司")持股 5%以上股东上海科汇投资管理有限公司 (以下简称"科汇投资")于 2024 年 7 月 30 日与茹菲签署了《股份转让协议》,将科汇投资 持有的 9,500,000 股(占公司总股本的 7.02%)公司股份转让给茹菲。具体内容详见公司于 2024 年 8 月 1 日在上海证券交易所网站(www.sse.com.cn)披露的《关于持股 5%以上股东与 其股东之间协议转让公司股份暨权益变动的提示性公告》(公告编号:2024-028)以及《简式 权益变动报告书》。 二、股份过户完成及协议转让前后持股情况 上述协议转让于 2024 年 8 月 22 日取得中国证券登记结算有限责任公司出具的《证券过 户登记确认书》,确认股东科汇投资通过协议方式转让给茹菲 ...
呈和科技:上半年实现增收增利,继续看好公司稳健成长
Guoxin Securities· 2024-08-19 01:41
Investment Rating - The report maintains an "Outperform" rating for Chenghe Technology (688625 SH) [2][4] Core Views - Chenghe Technology achieved steady revenue and profit growth in H1 2024, with total operating revenue reaching 414 million yuan, up 12 02% YoY, and net profit attributable to shareholders of 128 million yuan, up 17 37% YoY [2][6] - The company's core products, nucleating agents and synthetic hydrotalcite, continue to gain market share through product upgrades and R&D investments, driving revenue growth [2][6] - Gross margin improved to 45 09% in H1 2024, up 1 56 percentage points from 2023, while the expense ratio dropped to 8 83%, the lowest since its IPO [2][6] - The IPO-funded project in Guangzhou is progressing well, with 14,400 tons/year of capacity already operational and an additional 22,200 tons/year expected to be completed by September 2024 [2][8] Financial Performance - In H1 2024, the nucleating agent business generated 253 million yuan in revenue, up 27 67% YoY, with a gross margin of 56 78% [2][6] - The synthetic hydrotalcite business achieved 580,000 yuan in revenue, up 20 54% YoY, with a gross margin of 48 35%, up 3 92 percentage points from 2023 [2][6] - Operating cash flow increased by 20 50% YoY to 103 million yuan in H1 2024 [2][6] Industry and Product Outlook - Nucleating agents are widely used in polypropylene (PP) modification, with increasing demand in lithium battery materials and automotive components [2][8] - Synthetic hydrotalcite is expanding its applications beyond PVC stabilization, including agricultural films and spandex production, due to its eco-friendly and performance-enhancing properties [2][8] - The domestic market for nucleating agents and synthetic hydrotalcite has significant import substitution potential, supporting Chenghe Technology's growth [2][10] Financial Forecasts - Revenue is projected to grow to 979 million yuan in 2024, 1 152 billion yuan in 2025, and 1 334 billion yuan in 2026, with YoY growth rates of 22 5%, 17 6%, and 15 8% respectively [3] - Net profit attributable to shareholders is expected to reach 268 million yuan in 2024, 326 million yuan in 2025, and 387 million yuan in 2026, with YoY growth rates of 18 7%, 21 6%, and 18 5% respectively [3] - EPS is forecasted at 1 98 yuan in 2024, 2 41 yuan in 2025, and 2 86 yuan in 2026, with a PE ratio of 18 0x, 14 8x, and 12 5x respectively [3][10]
呈和科技:第三届董事会第四次会议决议公告
2024-08-16 11:03
证券代码:688625 证券简称:呈和科技 公告编号:2024-031 呈和科技股份有限公司 第三届董事会第四次会议决议公告 本公司董事会及全体董事成员保证公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 (一)呈和科技股份有限公司(以下简称"公司")第三届董事会第四次会议的通知及 会议资料已于 2024 年 8 月 6 日以电子邮件、专人送达和电话通知等方式向全体董事、监事及 高级管理人员送达。董事会会议通知包括会议的相关材料,同时列明了会议的召开时间、地 点、内容和方式。 (二)本次会议于 2024 年 8 月 15 日上午在公司天河会议室召开,采取现场和通讯投票 的方式进行表决。本次会议应出席董事七人,实际出席董事七人。会议由董事长仝佳奇先生 主持,公司全体监事及高级管理人员列席了本次会议。 (三)本次会议的召集和召开程序符合《中华人民共和国公司法》(以下简称《公司法》) 《中华人民共和国证券法》(以下简称《证券法》)《上海证券交易所科创板股票上市规则》 等相关法律、行政法规、部门规章、规范性文件及《呈和科技股份有限公司章 ...
呈和科技:2024年半年度募集资金存放与使用情况专项报告
2024-08-16 11:03
2024 年半年度募集资金存放与使用情况专项报告 公司董事会及全体董事成员保证公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《上市公司监管指引第 2 号——上市公司募集资金管理和 使用的监管要求(2022 年修订)》(证监会公告〔2022〕15 号)《上海证券交易所科创板上 市公司自律监管指引第 1 号——规范运作》以及《上海证券交易所上市公司自律监管指南第 1 号——公告格式》的相关规定,呈和科技股份有限公司(以下简称"呈和科技"、"公司") 就 2024 年半年度募集资金存放与使用情况作如下专项报告: 一、募集资金基本情况 (一)发行股票实际募集资金金额、资金到账时间 证券代码:688625 证券简称:呈和科技 公告编号:2024-030 呈和科技股份有限公司 1、2021 年首次公开发行股票募集资金 经中国证券监督管理委员会《关于同意呈和科技股份有限公司首次公开发行股票注册的 批复》(证监许可[2021]1398 号),呈和科技向社会公众首次公开发行人民币普通股(A 股) 33,333,400 股,每股面值人民币 1 ...
呈和科技:第三届监事会第十三次会议决议公告
2024-08-16 11:03
证券代码:688625 证券简称:呈和科技 公告编号:2024-029 呈和科技股份有限公司 第三届监事会第十三次会议决议公告 本公司监事会及全体监事成员保证公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 (一)呈和科技股份有限公司(以下简称"公司")第三届监事会第十三次会议的通知 及会议资料已于 2024 年 8 月 6 日以电子邮件、专人送达和电话通知等方式向全体监事、高级 管理人员送达,监事会会议通知包括会议的相关材料,同时列明了会议的召开时间、地点、 内容和方式。 (二)本次会议于 2024 年 8 月 15 日下午在公司天河会议室召开,采取现场和通讯投票 的方式进行表决。本次会议应出席监事三人,实际出席监事三人。会议由监事会主席何洁冰 女士主持,公司部分高级管理人员列席了本次会议。 (三)本次会议的召集和召开程序符合《中华人民共和国公司法》《上海证券交易所科 创板股票上市规则》等相关法律、行政法规、部门规章、规范性文件及《公司章程》的规定, 会议决议合法、有效。 二、监事会会议审议情况 与会监事经认真审议和表决,形成 ...
呈和科技(688625) - 2024 Q2 - 季度财报
2024-08-16 11:03
Financial Performance - The company reported a revenue of RMB 500 million for the first half of 2024, representing a 15% increase compared to the same period last year[1]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY for the first half of 2024, representing a 15% year-over-year growth[11]. - The company's operating revenue for the first half of the year reached ¥414,059,355.83, representing a 12.02% increase compared to the same period last year[16]. - Net profit attributable to shareholders was ¥127,677,290.91, marking a 17.37% growth year-over-year[16]. - The net profit after deducting non-recurring gains and losses was ¥126,707,837.57, which is a 22.73% increase from the previous year[16]. - The basic earnings per share for the first half of the year was ¥0.94, up 16.05% from ¥0.81 in the same period last year[17]. - The company achieved a revenue of RMB 414.06 million in the first half of 2024, representing a year-on-year growth of 12.02%[48]. - The net profit attributable to shareholders reached RMB 127.68 million, an increase of 17.37% compared to the previous year[48]. - The net profit excluding non-recurring items was RMB 126.71 million, reflecting a growth of 22.73% year-on-year[48]. User Growth - User data showed a growth in active users by 20%, reaching a total of 1.2 million users by June 2024[1]. - User data indicates a growth in active users, reaching 500,000, which is a 20% increase compared to the previous period[11]. - User data showed an increase in active users, reaching 2 million, which is a 15% increase compared to the previous period[96]. Revenue Guidance and Outlook - The company expects a revenue growth guidance of 10-15% for the second half of 2024, driven by new product launches and market expansion strategies[1]. - The company has provided a positive outlook for the second half of 2024, projecting a revenue growth of 10% to 12%[11]. - The company provided a positive outlook for the next quarter, projecting a revenue growth of 25% and aiming to reach $625 million[97]. Research and Development - Research and development expenses increased by 25%, focusing on new polymer materials and additives[1]. - The company has invested 50 million CNY in R&D for new polymer technologies aimed at improving product performance[11]. - Research and development expenses accounted for 4.02% of operating revenue, a decrease of 0.26 percentage points compared to the previous year[18]. - Research and development expenses were RMB 16.64 million, up 5.10% from the previous year[55]. - The company has applied for three new domestic invention patents during the reporting period, indicating ongoing innovation in core technologies[33]. - The company has developed a β crystal toughening nucleating agent production technology, which is a first in the industry, enhancing polypropylene's nucleation efficiency[33]. - The company is focusing on developing new products such as composite additives and anti-yellowing CPP film composite agents, targeting high-end markets[39]. Market Expansion - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share by the end of 2025[1]. - The company is expanding its market presence in Southeast Asia, targeting a 30% increase in sales in that region by the end of 2024[11]. - The company is actively pursuing partnerships with international firms to leverage advanced technologies and expand its product offerings[11]. Acquisitions and Investments - A strategic acquisition of a local competitor is in progress, expected to enhance production capacity by 40%[1]. - A strategic acquisition of a local competitor is in progress, which is anticipated to enhance the company's production capacity by 25%[11]. - The company is exploring potential acquisitions to strengthen its market position, with a budget of $200 million allocated for this purpose[96]. - The company has invested RMB 100 million in a private equity fund, with a total investment amount of RMB 100 million as of the reporting period[65]. - The company has invested RMB 45.09 million in the construction of a new high-performance polymer materials project, achieving an investment progress of 52.84%[103]. Environmental Commitment - The company has received ECOVADIS certification, indicating a commitment to sustainability and corporate social responsibility[10]. - The company emphasizes green and environmentally friendly production processes, aligning with its innovation-driven development strategy[32]. - The company has been awarded the title of "Green Factory" at both national and municipal levels, emphasizing its commitment to environmentally friendly production practices[45]. - The company has implemented effective pollution control measures, ensuring that all emissions meet legal and regulatory standards[75]. - The company is promoting green manufacturing initiatives, including energy conservation and clean production practices[76]. Financial Management and Compliance - The company has committed to a continuous and stable profit distribution policy, prioritizing cash dividends, with a minimum of 80% cash dividends for mature companies without major capital expenditure plans[93]. - The company will ensure that the buyback does not lead to non-compliance with listing conditions[90]. - The company will compensate investors for losses caused by the failure to fulfill commitments regarding stock price stability[91]. - The company has committed to long-term compliance with various commitments related to share restrictions and environmental responsibilities[84]. Operational Efficiency - The company is focusing on enhancing operational efficiency and expanding its market presence both domestically and internationally[18]. - The company plans to enhance its supply chain efficiency, aiming for a 15% reduction in operational costs by the end of 2024[11]. - The procurement strategy is based on a "sales-driven production" model, ensuring dynamic procurement plans aligned with current orders and inventory levels[31]. Financial Position - The company's total assets decreased by 8.58% to ¥3,026,643,223.47 compared to the end of the previous year[16]. - The company's cash and cash equivalents decreased by 58.95% to RMB 261.86 million, primarily due to repayments of bank acceptance bills and cash dividends[57]. - The company's accounts receivable at the end of the reporting period amounted to RMB 243.96 million, accounting for 58.92% of the current operating revenue[52]. - The company's total liabilities decreased from ¥2,033,563,405.53 to ¥1,793,959,371.50, a decline of approximately 11.8%[116]. Compliance and Governance - The company adheres to the accounting standards set by the Ministry of Finance and ensures that the financial statements reflect the true financial condition and operating results[146]. - The company has not faced any penalties from environmental protection departments during the reporting period[69]. - The company has no significant litigation or arbitration matters during the reporting period[100].